TPU scientists succeeded to solve the most difficult problem and obtain ‘pure’ lutetium-177 without harmful impurities.

The city administration of Shijiazhuang and TPU signed an agreement on cooperation.

A radiopharmaceutical based on technetium will pass preclinical tests by the end of 2018, reported by TPU scientists at the press conference.

Over 300 of young researchers and students, as well as experts in the field of nuclear physics from various cities and countries came to Tomsk Polytechnic University to the international conference &l...

Tomsk Polytechnic University began commercial supply of orthophosphoric acid based on phosphorus-32 isotope, which is used for biochemical study, diagnostics and therapy of cancer diseases. A producti...

Last week the leading nuclear scientists of Russia gathered in Tomsk to celebrate the anniversary of the research reactor of Tomsk Polytechnic University. As part of the celebration the university hos...

A radiopharmaceutical for advanced identification of cancer, labeled with the technetium-99 isotope, is ready for the preclinical-phase trial. Scientists from Tomsk Polytechnic University, Tomsk Resea...